Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
The formulation and delivery of biopharmaceutical drugs, such as monoclonal antibodies
and recombinant proteins, poses substantial challenges owing to their large size and …
and recombinant proteins, poses substantial challenges owing to their large size and …
Diabetes technology—continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline
AL Peters, AJ Ahmann, T Battelino… - The Journal of …, 2016 - academic.oup.com
Objective: To formulate clinical practice guidelines for the use of continuous glucose
monitoring and continuous subcutaneous insulin infusion in adults with diabetes …
monitoring and continuous subcutaneous insulin infusion in adults with diabetes …
Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia
AV Maker, R Sheikh, V Bhagia… - … Archives of Surgery, 2017 - Springer
Purpose Indications for total pancreatectomy (TP) have increased, including for diffuse main
duct intrapapillary mucinous neoplasms of the pancreas and malignancy; therefore, the …
duct intrapapillary mucinous neoplasms of the pancreas and malignancy; therefore, the …
Corneal confocal microscopy shows an improvement in small-fiber neuropathy in subjects with type 1 diabetes on continuous subcutaneous insulin infusion compared …
Improved glycemic control is the only treatment that has been shown to be effective for
diabetic peripheral neuropathy in patients with type 1 diabetes (1). Continuous …
diabetic peripheral neuropathy in patients with type 1 diabetes (1). Continuous …
Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with type 1 diabetes
P Beato‐Víbora, E Yeoh, H Rogers… - Diabetic …, 2015 - Wiley Online Library
Aim To evaluate the sustainability of the benefits of continuous subcutaneous insulin
infusion therapy in routine practice in a cohort of adults with diabetes. Methods The clinical …
infusion therapy in routine practice in a cohort of adults with diabetes. Methods The clinical …
Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes
L Leelarathna, SA Roberts, A Hindle… - Diabetic …, 2017 - Wiley Online Library
Aims To compare long‐term HbA1c changes associated with different insulin pumps during
routine care in a large cohort of adults with Type 1 diabetes representative of other clinic …
routine care in a large cohort of adults with Type 1 diabetes representative of other clinic …
The effectiveness and risks of programming an insulin pump to counteract the dawn phenomenon in type 1 diabetes
MF Bouchonville, JJ Jaghab, E Duran-Valdez… - Endocrine Practice, 2014 - Elsevier
Objective Continuous subcutaneous insulin infusion (CSII) programming for an early
morning increase in insulin delivery is frequently recommended to counteract the rise in …
morning increase in insulin delivery is frequently recommended to counteract the rise in …
Clinical outcomes after 1 year of augmented insulin pump therapy in patients with diabetes in a specialized diabetes center in Medellín, Colombia
A Ramirez-Rincon, J Hincapie-García… - Diabetes technology …, 2016 - liebertpub.com
Background: Type 1 diabetes can be difficult to control. Augmented pump therapy (CSII-
rtCGM) has become an important tool for controlling blood glucose and decreasing …
rtCGM) has become an important tool for controlling blood glucose and decreasing …
A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain
P Beato-Víbora, A Chico-Ballesteros… - Diabetes Research and …, 2018 - Elsevier
Aims To assess safety and benefits of continuous subcutaneous insulin infusion (CSII)
therapy in a cohort of type 1 diabetes patients in Spain. Methods A web-based national …
therapy in a cohort of type 1 diabetes patients in Spain. Methods A web-based national …
Long-term effects of continuous subcutaneous insulin infusion in adults with type 1 diabetes mellitus patients: Results of a public healthcare system
J Moreno-Fernandez, LM López, FJ Gomez… - … , Diabetes y Nutrición, 2021 - Elsevier
Aim To evaluate the long-term clinical effect of continuous subcutaneous insulin infusion
(CSII) in adult type 1 diabetes mellitus (T1DM) patients in a regional public healthcare …
(CSII) in adult type 1 diabetes mellitus (T1DM) patients in a regional public healthcare …